- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04155021
Knowledge and Attitude in Perioperative Erythrocyte Transfusion in Medical Personnel in Siriraj Hospital
May 18, 2022 updated by: Mingkwan Wongyingsinn, MD, Siriraj Hospital
Knowledge and Attitude in Perioperative Erythrocyte Transfusion in Medical Personnel of the Department of Anesthesiology and Department of Orthopedic Surgery in Siriraj Hospital
This study is designed to explore the correlation between knowledge and attitude in perioperative erythrocyte transfusion in medical personnel.
Study Overview
Status
Completed
Conditions
Detailed Description
Inappropriate erythrocyte transfusion is still have high incidence even lots of the transfusion guidelines and researches was launched.
Unnecessary or delayed transfusion can cause morbidity and mortality.
This study is descriptive research, questionnaire based survey conducted to explore the correlation between knowledge and attitude in perioperative erythrocyte transfusion in medical personnel in Siriraj Hospital.
Study Type
Observational
Enrollment (Actual)
250
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Bangkok, Thailand, 10700
- Siriraj Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Post-graduated medical personnel in Siriraj Hospital who associated with erythrocyte transfusion practice.
Description
Inclusion Criteria:
- Post-graduated medical personnel in Siriraj Hospital
Exclusion Criteria:
- Post-graduated medical personnel in Siriraj Hospital who refuse to participate
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Knowledge in perioperative erythocyte transfusion in medical personnel in Siriraj Hospital
Time Frame: 10 minutes
|
We aim to explore the reason of high incidence of inappropriate transfusion by conduct the questionnaire, about knowledge and attitude in perioperative erythocyte transfusion in medical personnel in Siriraj Hospital.
Knowledge part will measure followed by transfusion guideline of Hematology and Anesthesiology, Siriraj Hospital and attitude toward perioperative transfusion will collect and analyse
|
10 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Attitude in perioperative erythocyte transfusion in medical personnel in Siriraj Hospital
Time Frame: 10 minutes
|
We aim to explore the reason of high incidence of inappropriate transfusion by conduct the questionnaire, about knowledge and attitude in perioperative erythocyte transfusion in medical personnel in Siriraj Hospital.
Knowledge part will measure followed by transfusion guideline of Hematology and Anesthesiology, Siriraj Hospital and attitude toward perioperative transfusion will collect and analyse
|
10 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 15, 2020
Primary Completion (Actual)
January 15, 2022
Study Completion (Actual)
May 15, 2022
Study Registration Dates
First Submitted
November 5, 2019
First Submitted That Met QC Criteria
November 5, 2019
First Posted (Actual)
November 7, 2019
Study Record Updates
Last Update Posted (Actual)
May 19, 2022
Last Update Submitted That Met QC Criteria
May 18, 2022
Last Verified
May 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- SIRB421
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.